The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)

BACKGROUND: Hyperbaric oxygen (HBO) therapy is an effective adjunct treatment for ischemic disorders such as chronic infection or chronic wounds. It combines hyperoxic effects with the stimulating potential of post-therapeutic reactive hypoxia. As its crucial effects, stimulation of fibroblast growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Susanne, Wermker, Kai, Poetschik, Harald, Ziebura, Thomas, Kleinheinz, Johannes
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022549/
https://www.ncbi.nlm.nih.gov/pubmed/21176170
http://dx.doi.org/10.1186/1746-160X-6-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022549/
https://www.ncbi.nlm.nih.gov/pubmed/21176170
http://dx.doi.org/10.1186/1746-160X-6-29

Ejemplares similares